Act now to help give your patients with CKD associated with T2D a different outcome

Slow CKD progression and reduce the risk of associated CV events with Kerendia¹

Learn more about the kinds of patients who may benefit from Kerendia

CKD=chronic kidney disease; CV=cardiovascular; T2D=type 2 diabetes.

References:

Kerendia European Summary of Product Characteristics (SmPC); March 2022. Return to content

© 2025 Bayer SG

This website was created by Bayer
and is intended to provide information to
healthcare professionals in Singapore only.
PP-KER-SG-0166-1 (01/25)